These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3026018)

  • 41. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
    Dajani A
    J Int Med Res; 2001; 29(4):257-69. PubMed ID: 11675898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
    Retsema JA; English AR; Girard A; Lynch JE; Anderson M; Brennan L; Cimochowski C; Faiella J; Norcia W; Sawyer P
    Rev Infect Dis; 1986; 8 Suppl 5():S528-34. PubMed ID: 3026001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stability of sulbactam/ampicillin in diluents for parenteral administration.
    Mushinsky RF; Reynolds ML; Nicholson CA; Crider LL; Forcier GA
    Rev Infect Dis; 1986; 8 Suppl 5():S523-7. PubMed ID: 3026000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis.
    Black J; Hunt TL; Godley PJ; Matthew E
    J Infect Dis; 1987 May; 155(5):968-72. PubMed ID: 3494088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An open comparative study of the efficacy and safety of sultamicillin versus cefaclor in the treatment of acute otitis media in children.
    Biolcati AH
    J Int Med Res; 1992; 20 Suppl 1():31A-43A. PubMed ID: 1451927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
    De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M
    J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of ampicillin-resistant acute otitis media in the chinchilla.
    Reilly JS; Doyle WJ; Cantekin EI; Supance JS; Kim HK; Rohn DD; Bluestone CD
    Arch Otolaryngol; 1983 Aug; 109(8):533-5. PubMed ID: 6307238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
    Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
    Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
    J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
    Azimi PH; Barson WJ; Janner D; Swanson R
    Pediatr Infect Dis J; 1999 Jul; 18(7):609-13. PubMed ID: 10440436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.
    ROgers HJ; Bradbrook ID; Morrison PJ; Spector RG; Cox DA; Lees LJ
    J Antimicrob Chemother; 1983 May; 11(5):435-45. PubMed ID: 6307964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized comparative study of sulbactam plus ampicillin vs. metronidazole plus cefotaxime in the management of acute appendicitis in children.
    Foster MC; Kapila L; Morris DL; Slack RC
    Rev Infect Dis; 1986; 8 Suppl 5():S634-8. PubMed ID: 3026017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
    Crombleholme WR; Ohm-Smith M; Robbie MO; DeKay V; Sweet RL
    Am J Obstet Gynecol; 1987 Feb; 156(2):507-12. PubMed ID: 3030109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam.
    Norden CW; Budinsky A
    J Infect Dis; 1990 Jan; 161(1):52-3. PubMed ID: 2295859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulbactam/ampicillin in paediatric infections.
    Dajani AS
    Drugs; 1988; 35 Suppl 7():35-8. PubMed ID: 3065053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A clinical trial with ampicillin and sulbactam in various infections].
    Kanra G; Seçmeer G; Tarim OF; Calikoğlu AS; Ecevit Z; Günel M
    Mikrobiyol Bul; 1988; 22(4):284-95. PubMed ID: 3252119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sultamicillin experiences in the field of internal medicine.
    Hara K; Kobayashi H
    APMIS Suppl; 1989; 5():51-6. PubMed ID: 2660872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
    Hemsell DL
    Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical use of sultamicillin (ampicillin/sulbactam) in children.
    López EL; Rivas NA
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S12-4; discussion S20-1. PubMed ID: 9519909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.